DAFTAR PUSTAKA
1. Irwin M, Arthur ZE, Klauss WK, Frank A, Lowell AG, Stephen K (eds).
Fitzpatrick dermatology in general medicine. 6th ed. New York: McGraw-Hill Professional; 2003.p.476-42.
2. Djuanda A, Hamzah M, Alsah S (eds). Ilmu penyakit kulit dan kelamin. Edisi
ke 7. Jakarta: Fakultas Kedokteran Universitas Indonesia; 2016.
3. Cantika AS. Hubungan derajat keparahan psoriasis terhadap kualitas hidup
penderita. Jurnal Universitas Diponegoro. 2012;17: 32-40.
4. Kurd SK, Toxel AB, Paul CC, Gelfand JM. The risk of depression, anxiety
and suicidality in patients with psoriasis: A population-based cohort study. Arh Dermatol. 2010;146(8):891-5.
5. Henseler T, Christophers E. Psoriasis of early and late onset: characterization
of two types of psoriasis vulgaris. JAm Acad Dermatol. 1985;13(3):450–6.
6. Gerdes S, Zahl VA, Weichenthal M, Mrowietz U. Smoking and alcohol intake
in severely affected patients with psoriasis in Germany. Dermatology on Kargel Medicine Journal. 2009;220:38-43.
7. Wiryadi BE. Epidemiologic data of psoriatic patient in Dr. Cipto
Mangunkusumo General Hospital year 2000-2001 (dissertation); 2004.
8. Budiastuti A. Korelasi kadar TNF ɑ dan skor Psoriasis Area Severity Index
(PASI) pada pasien psoriasis. Media Medika Indonesiana. 2011;45(2):10-15.
9. Natali. Profil kadar prolaktin serum pada berbagai derajat keparahan penderita
psoriasis vulgaris di RSUP H. Adam Malik Medan (skripsi). FK USU. 2012; 28:1-9.
10.Pomantow PM. Profil psoriasis di Poliklinik Kulit dan Kelamin RSUP. Prof.
Dr. R. D. Kandou Manado periode Januari 2006-Desember 2008 (skripsi). Manado:FK Unsrat; 2009.
11.Utami AT. Hubungan psoriasis dengan tekanan darah pada pasien psoriasis di
Poliklinik Kulit dan Kelamin RSUP Dr. M. Djamil Padang periode Januari 2014-Desember 2016 (skripsi). Padang: FK Unand; 2016.
12.Khalid U,Hansen PR, Gislason GH, Lindhardsen J, Kristensen SL, Winther
SA, et al. Psoriasis and new-onset diabetes: a Danish nationwide cohort study. 2013;36(8):2402-7.
13.Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2006;298:321-8.
14.Cohen AD, Sherf M, Vidavsky L, Shapiro J, Meyerovitch J. Association
between psoriasis and metabolic syndrome. Dermatology on Kargel Medicine Journal. 2008;216:152-155.
15.Azfar RS, Gelfand JM. Psoriasis and metabolic disease: Epidemiology and
pathophysiology. Curr Opin Rheumatol. 2008;20:416-22.
16.Setyorini M, Triestianawati W, Wiryadi BE, Jacoeb TNA. Proporsi sindrom
metabolik pada pasien psoriasis vulgaris berdasarkan kriteria national cholesterol education program adult treatment panel III di RS Dr. Cipto Mangunkusumo. 2010;39(1):2-9.
17.Kalkan G, Karadag AS. The association between psoriasis and cardiovascular
diseases. Eur J Gen Med. 2013;10:10-6.
18.Nestle FO., Kaplan DH. and Barker J. Mechanisme of disease psoriasis. N
Engl J Med. 2009;361(5):496-509.
19.Parisi R, Symmons DPM, Griffiths CEM, Ashcroft DM. Global epidemiology
of psoriasis: a systematic review ofincidence and prevalence. J Invest Dermatol. 2013;133(2):377–85.
20.Deny F, Lestari S, Isramiharti, Zainal, Salmiah A. Respon klinis dan
histologik pada psoriasis vulgaris tipe plak rekalsitran yang diterapi metotreksat di RS Dr.M.Djamil Padang. Majalah Kedokteran Universitas Andalas. 2004;28(2):1-4.
21.Gudjonsson JE, Elder JT. Fitzpatrick’s dermatology in general medicine. 7th
ed. United States of America: McGraw Hill; 2008.p.169-93.
22.Joshi R. Immunopathogenesis of psoriasis. Indian J Dermatol Venereol
Leprol. 2004;70:10-2.
23.Traub M, Marshall K. Psoriasis – pathophysiology, conventional, and
alternative approaches to treatment. Altern Med Rev. 2007;12:319-330.
24.Gaspari AA. Innate and adaptive immunity and the pathophysiology of
psoriasis. J Am Acad Dermatol. 2006;54:S67-80.
25.James WD, Berger TG, Elston DM. Disease of the skin clinical dermatology
26.Ashcroft DM, Li WP, Griffiths CM. Therapeutic strategis for psoriasis. J of Clin Pharm and Ther. 2000;25:1-10.
27.Murray RK, Granner DK, Rodwell VW. Biokimia harper (27 ed.). Jakarta:
EGC; 2009.
28.Henrikson JE, Bech Nielsen H. 2009. Blood glucose levels.
http://www.netdoctor.co.uk/healthadvice/facts/diabetesbloodsugar - Diakses 29 September 2017.
29.Depkes RI. Rencana pembangunan kesehatan menuju indonesia sehat 2010.
Jakarta; 1999.
30.Schteinger DE. Peranan ankreas dalam mengatur metabolisme glukosa. Edisi
6. Jakarta: EGC; 2005.p.1259-70.
31.Bishop M, Fody E, Schoeff L. Clinical Chemistry - Techniques, Principles,
Correlations.2010;1.p788.
32.Ksenia TMD, James HN. A Review of technical challenges to obtaining
accurate results. J Diabetes Sci Technol. 2009;3(4):971–980
.
33.Guyton AC, Hall J. Anatomi fisiologi kedokteran. Edisi 9. Jakarta: Penerbit
Buku Kedokteran EGC; 1997.
34.Dalimartha S. Atlas tumbuhan obat indonesia. Jakarta: Trubus Agriwidya;
2007.p.36.
35.Sheidel C. Basic concept in physiology: A Student’s urvival guide. New
York: Mc Graw Hill; 2001.
36.Ronald A, Sacher. Tinjauan klinis hasil pemeriksaan laboratorium. Jakarta:
Gramedia Pustaka Utama; 2004.
37.Tandra, Hans. Panduan engkap mengenal dan mengatasi diabetes dengan
cepat dan mudah. Jakarta: Gramedia Pustaka Utama; 2007.
38.Nabyl. Mengenal Diabetes. Jakarta : Gramedia Pustaka Utama; 2009.
39.Kariadi, Hastuti S. Panduan lengkap untuk diabetes. Jakarta: Mizan Media
Utama; 2009.
40.Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic
syndrome: A systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013; 68(4):654-662.
41.Jucci A, Vignini M, Pelfini C, Criffo A, Fratino P. Psoriasis and insulin
secretion. Archives of Dermatological Research. 1977;257(3):239–246.
42.Yuni L. Hubungan psoriasis vulgaris dan Tumor Necrosis Factor Alpha
dengan sindrom etabolik (thesis). Yogyakarta: Universitas Gadjah Mada; 2013.
43.Ghazizadeh R, Shimizu H, Tosa M. Pathogenic mechanisms shared between
psoriasis and cardiovascular disease. Int J Med Sci. 2010;7(5):284-9.
44.Jiamton S, Suthipinittharm P, Kulthanan K, Chularojanamontri L,
Wongpraparut C, Silpa-archa N, et al. Clinical characteristics of Thai patients with psoriasis. J Med Assoc Thai. 2012;36:16-22.
45.Damayanti I. Hubungan Skor Psoriasis Area and Severity Index dan kualitas
hidup pasien psoriasis vulgaris di Rumah Sakit Umum Pusat Haji Adam Malik Medan. Medan: Fakultas Kedokteran Universitas Sumatera Utara; 2014.
46.Fitzpatrick BT, Richard AJ, Klaus W, Machiel KP, Dick S. Color atlas and
synopsis of clinical dermatology common and serious disease 3rd ed. United
States of America: McGraw-Hill Health Professions Division; 1997.p.76-102.
47.Kurniasari I, Yasmin I, Muslimin, Kabulrachman. Karakteristik psoriasis di
Poliklinik Kulit dan Kelamin RSUP Dr. Kariadi Semarang. Semarang: Fakultas Kedokteran Universitas Diponegoro; 2012.
48.Griffiths CEM, Champ RDR, Barker JNWN. Rook’s textbook of
Dermatology. 7th ed. Oxford: Blackwell Scientific Publication; 2004;35:1-68.
49.Sakai R, Matsui S, Fukushima M, Yasuda H, Miyauchi H, Miyachi Y.
Prognostic factor analysis for plaque psoriasis. Dermatology. 2005;11:103-6.
50.Hsu S, Papp K, Lebwohl M, Bagel J, Blauvelt A, Duffin K, et al. Consensus
guidelines for the management of plaque psoriasis. Arch Dermatol. 2005;148: 95–102.
51.Thamtono Y. Hubungan psoriasis dengan komorbiditas kardiovaskular.
2016;43(2):1-8.
52.Zulkarnain D. Profil pasien psoriasis vulgaris di poliklinik kulit dan kelamin
RSUP Dr. M. Djamil Padang periode Januari 2011-Desember 2014 (Skripsi). Fakultas Kedokteran Universitas Andalas; 2015.
53.Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM.
Dermatol. 2006;55(5):829-35.
54.Singh G, Aneja SPS. Cardiovascular comorbidity in psoriasis. Indian J
Dermatol. 2011; 56(5): 553-6.
55.Gisondi P, Tessari G, Conti A. Piaserico S, Schianchi S. Prevalence of
metabolic syndrome in patients with psoriasis: a hospital-based case–control study. British Journal of dermatologi. 2007;157:68-73.
